Intermittent Fasting Versus Diet to Stop Hypertension on Metabolic Risk Profile in Nonalcoholic Fatty Liver Patients

Intermittent Fasting Versus Dietary Approach to Stop Hypertension on Metabolic Risk Profile in Nonalcoholic Fatty Liver Patients

This study was conducted to compare between the effect of intermittent fasting and diatery approach to stop hypertension on metabolic risk profile in nonalcoholic fatty liver patients.

Non-alcoholic fatty liver is a liver disease linked to obesity, insulin resistance, type 2 diabetes, hypertension, hyperlipidemia, and metabolic syndrome. The subtype, non-alcoholic steatohepatitis, can lead to liver fibrosis, cirrhosis, hepatocellular carcinoma, and liver transplantation. The prevalence of Non-alcoholic fatty liver disease is increasing at the same rate as obesity, with the global prevalence estimated at 25%. By 2020, the burden of Non-alcoholic fatty liver is expected to exceed that of communicable disease in most regions.

Inclusion Criteria:

• Non-alcoholic fatty liver patients diagnosed by radiological ultrasound
• BMI >30
• All patients are sedentary lifestyle with little or no exercise.
• High lipid profile (total cholesterol > 200, LDL > 130, TAGs > 150) patients by laboratory investigation.
• High fasting insulin level > 20mlU/mL & high fasting Glucose level >100, HbA1c > 5.7 & high HOMA- IR > 2.5 patients by Laboratory investigation.
• High inflammatory markers (IL6) patients.
• Age ranged from 30 to 40 years old.

Exclusion Criteria:

• Alcoholic fatty liver patients.
• Cirrhosis patients.
• Diabetes patients.
• Cognitive impaired patients.
• History of epilepsy patients.
• Cardiac pacemaker patients.
• Anemic patients
• pregnancy